LOCTITE has launched a new range of flexible and rigid LED-curable adhesives — including LOCTITE AA 3951 / AA 3953 and LOCTITE AA 3961 / AA 3963 – developed to meet the stringent demands of modern medical device assembly.
The launch forms a key part of LOCTITE’s latest ‘Bonded for Life’ campaign, which highlights how its adhesive innovations are helping manufacturers meet growing demands for safer, smaller and more sophisticated medical devices, while accelerating production and navigating increasingly complex regulatory landscapes.
LOCTITE has been a trusted partner to medical device designers and manufacturers for decades, continuously advancing its adhesive technologies to meet the evolving demands of modern healthcare across both large and small-scale applications.
Today, LOCTITE offers one of the industry’s most diversified and comprehensive portfolios of adhesives, dispensing equipment and curing systems. Its offering includes more than 40 biocompatibility-tested products, and hundreds more formulated for non-invasive applications, supporting everything from advanced surgical instruments to high-volume production of disposables, diagnostic devices and next-generation wearable technologies.
“Our medical adhesives save more than just time,” said Paul Marshall, Marketing Head for UK, Ireland and Nordics at Henkel. “They give manufacturers the flexibility to design more advanced devices, improve production efficiency and meet the rigorous safety and performance standards required in today’s healthcare environment.
“Ultimately, by ensuring strong, reliable bonds in critical medical applications, our solutions can help protect patient well-being and support better clinical outcomes.”
To support the introduction of its new products, LOCTITE is also releasing dedicated whitepapers that explore their application, materials and the performance benefits they offer in modern medical device manufacturing.
The company’s newest formulations are also designed to reduce or eliminate materials of concern, addressing evolving regulations surrounding substances such as CMRs, SVHCs and skin irritants, while maintaining the highest levels of quality and reliability.
In parallel, LOCTITE assembly automation solutions continue to help customers boost productivity, reduce waste, and enhance operator safety. Its advanced LED-curing systems for light-cure acrylics deliver fast, energy-efficient curing with lower heat exposure, extending equipment life and improving operational safety. Meanwhile, its dispensing systems accommodate a wide range of adhesive types and packaging options, further minimising waste, supporting larger adhesive pack sizes and promoting safer manufacturing processes.
“Whether manufacturers are producing disposable, single-use devices that require high-speed, precision assembly and resistance to sterilisation or reusable devices that demand durability, biocompatibility and withstand multiple sterilisation cycles, our proven adhesives are engineered to meet all of these complex requirements with confidence,” said Paul.
LOCTITE, a global leader in adhesives, has launched a new range of flexible and rigid LED-curable adhesives — including LOCTITE AA 3951 / AA 3953 and LOCTITE AA 3961 / AA 3963 – developed to meet the stringent demands of modern medical device assembly.
The launch forms a key part of LOCTITE’s latest ‘Bonded for Life’ campaign, which highlights how its adhesive innovations are helping manufacturers meet growing demands for safer, smaller and more sophisticated medical devices, while accelerating production and navigating increasingly complex regulatory landscapes.
“Our medical adhesives save more than just time,” said Paul Marshall, Marketing Head for UK, Ireland and Nordics at Henkel. “They give manufacturers the flexibility to design more advanced devices, improve production efficiency and meet the rigorous safety and performance standards required in today’s healthcare environment.
“Ultimately, by ensuring strong, reliable bonds in critical medical applications, our solutions can help protect patient well-being and support better clinical outcomes.”
To support the introduction of its new products, LOCTITE is also releasing dedicated whitepapers that explore their application, materials and the performance benefits they offer in modern medical device manufacturing.
The company’s newest formulations are also designed to reduce or eliminate materials of concern, addressing evolving regulations surrounding substances such as CMRs, SVHCs and skin irritants, while maintaining the highest levels of quality and reliability.
“Whether manufacturers are producing disposable, single-use devices that require high-speed, precision assembly and resistance to sterilisation or reusable devices that demand durability, biocompatibility and withstand multiple sterilisation cycles, our proven adhesives are engineered to meet all of these complex requirements with confidence,” said Paul.
